4-OXOQUINOLINE COMPOUND AND ITS USING AS HIV INTEGRASE INHIBITOR Russian patent published in 2006 - IPC C07D215/56 C07D401/06 C07D409/06 C07D417/06 A61K31/47 A61P31/12 A61P31/18 

Abstract RU 2275361 C2

FIELD: organic chemistry, biochemistry, medicine.

SUBSTANCE: invention relates to a new biologically active compound of 4-oxoquinoline that is useful as an anti-HIV agent and to its pharmaceutically acceptable salt. Invention describes an anti-HIV agent comprising compound of 4-oxoquinoline represented by the following formula [I] or its pharmaceutically acceptable salt as an active component wherein ring Cy represents phenyl group, naphthyl group or pyridyl group and each this group is substituted optionally with 1-5 substituted chosen from the following group A wherein A represents the group consisting of cyano-group, phenyl group, nitro-group, halogen atom, (C1-C4)-alkyl group, halogen-(C1-C4)-alkyl group, halogen-(C1-C4)-alkoxy-group, -ORa1, -SRa1, -NRa1Ra2, -CONRa1Ra2, -SO2NRa1Ra2, -NRa1CORa3, -SO2Ra3, -NRa1SO2Ra3 and -COORa1 wherein Ra1 and Ra2 are similar or different and each represents hydrogen atom, (C1-C4)-alkyl group or benzyl group, and Ra3 represents (C1-C4)-alkyl group; R1 represent a substitute chosen from the following group B, or (C1-C10)-alkyl group optionally substituted with 1-3 substitutes chosen from halogen atom and the following group B wherein the group B represents the group consisting of phenyl group optionally substituted with phenyl group or 1-5 halogen atoms; (C3-C6)-cycloalkyl group, imidazolyl group, benzothiophenyl group, thiazolyl group optionally substituted with 1-3 (C1-C6)-alkyl groups, morpholinyl group, pyridyl group, -ORa4, -SRa4, -NRa4Ra5, -CONRa4Ra5, -SO2NRa4Ra5, -CORa6, -NRa4CORa6, -SO2Ra6, -NRa4SO2Ra6, -COORa4 and -NRa5COORa6 wherein Ra4 and Ra5 are similar or different and each represents hydrogen atom, (C1-C4)-alkyl group or phenyl group; Ra6 represents (C1-C4)-alkyl group; R2 represents hydrogen atom or (C1-C4)-alkyl group; R31 represents hydrogen atom, cyano-group, hydroxy-group, halogen atom or (C1-C4)-alkoxy-group; X represents -C-R32, and Y represents -C-R33 or nitrogen atom wherein R32 and R33 are similar or different and each represents hydrogen atom, cyano-group, halogen atom, pyrrolidinyl group, (C1-C10)-alkyl group optionally substituted with 1-3 halogen atoms, -ORa7, -SRa7, -NRa7Ra8, -NRa7CORa9, -COORa10 or -N=CH-NRa10Ra11 wherein Ra7 and Ra8 are similar or different and each represents hydrogen atom, phenyl group or (C1-C10)-alkyl group optionally substituted with (C3-C6)-cycloalkyl group or hydroxy-group; Ra9 represents (C1-C4)-alkyl group and Ra10 and Ra11 are similar or different and each represents hydrogen atom or (C1-C4)-alkyl group. Also, invention describes compound of the formula (III) given in the invention description, integrase inhibitor, antiviral agent, ant-HIV composition, anti-HIV agent, using compound of 4-oxoqionoline, method for inhibition of integrase activity, method for prophylaxis or treatment of viral infectious disease, pharmaceutical composition used for inhibition of integrase activity, antiviral composition and commercial package (variants). Invention provides the development of a pharmaceutical agent possessing inhibitory effect on activity of integrase.

EFFECT: valuable medicinal properties of compound, agent and composition.

40 cl, 7 tbl, 250 ex

Similar patents RU2275361C2

Title Year Author Number
6-(HETEROCYCLYL-SUBSTITUTED BENZYL)-4-OXOQUINOLINE DERIVATIVE AND USE THEREOF AS HIV INTEGRASE INHIBITOR 2007
  • Satokh Motokhide
  • Aramaki Khisateru
  • Jamasita Masaki
  • Inoue Masafumi
  • Kavakami Khirosi
  • Sinkaj Khisasi
  • Nakamura Khirosi
  • Matsuzaki Judzi
  • Vamaki Suiti
RU2399616C1
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY 2007
  • Iikura Khitosi
  • Kheudokh Ikumi
  • Aoki Tosikhiro
  • Furuiti Norijuki
  • Matsusita Masajuki
  • Vatanabe Fumio
  • Ozava Savako
  • Sakajtani Masakhiro
  • Kho Pil-Su
  • Tomii Jasusi
  • Takanasi Kendzi
  • Kharada Naoki
RU2428420C2
STABLE CRYSTAL OF 4-OXOQUINOLINE COMPOUND 2005
  • Satokh Motokhide
  • Motomura Takakhisa
  • Matsuda Takasi
  • Kondo Kentaro
  • Ando Kodzi
  • Matsuda Kodzi
  • Mijake Sudzi
  • Uekhara Khideto
RU2330845C1
TETRAHYDROCARBOLINE DERIVATIVE 2011
  • Okhata Akira
  • Nakatani Singo
  • Sugijama Tetsuja
  • Morimoto Takasi
RU2572818C2
SULFONAMIDE PERI-SUBSTITUTED BICYCLES FOR TREATMENT OF OCCLUSIVE AFFECTION OF ARTERIES 2005
  • Chzhou Nian'
  • Singkh Dzhasbir
  • Garni Mark
  • Khejtgan Dzhordzheta
  • Juj Pehn
  • Zembauehr Dehvid
RU2403240C2
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS 2005
  • Adida Rua Sara S.
  • Khejzlvud Anna R.
  • Grotenkhejs Peter D.,J.
  • Van Gur Frederik F.
  • Singkh Ashvani K.
  • Chzhou Tszinlan'
  • Makkartni Dzhejson
RU2528046C2
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE 2005
  • Adida Rua Sara S
  • Khejzlvud Anna R
  • Grotenkhejs Peter D J
  • Van Gur Frederik F
  • Singkh Ashvani K
  • Chzhou Tszinlan'
  • Makkartni Dzhejson
RU2525115C2
ATP-BINDING CASETTE TRANSPORTER MODULATORS 2005
  • Adida Rua Sara S.
  • Khejzlvud Anna R.
  • Grotenkhejs Peter D. J.
  • Van Gur Frederik F.
  • Singkh Ashvani K.
  • Chzhou Tszinlan'
  • Makkartni Dzhejson
RU2382779C2
HETEROCYCLIC DERIVATIVES AND USE THEREOF 2015
  • Moon, Hyung Jo
  • Kong, Minjung
  • Kim, Mi Sun
  • Kim, Byungho
  • Kim, Hye Jung
  • Ko, Kwang Seok
  • Yun, Jee Hun
  • Park, Heon Kyu
  • Kim, Jungsook
  • Lee, Soon Ok
  • Im, Junhwan
  • Lee, Sang Hwi
  • Park, Chan Hee
RU2711502C2
FLUOROQUINOLONE COMPOUNDS BASED ON PYRIDOXINE DERIVATIVES, HAVING ANTIBACTERIAL PROPERTIES 2019
  • Shtyrlin Yurij Grigorevich
  • Shtyrlin Nikita Valerevich
  • Pugachev Mikhail Vladimirovich
  • Garipov Marsel Radyikovich
  • Iksanova Alfiya Gabdulakhatovna
  • Kayumov Ajrat Rashitovich
RU2713932C1

RU 2 275 361 C2

Authors

Satokh Motokhide

Kavakami Khirosi

Itokh Josikharu

Sinkaj Khisasi

Motomura Takakhisa

Aramaki Khisateru

Matsuzaki Judzi

Vatanabe Vataru

Vamaki Suiti

Dates

2006-04-27Published

2003-11-20Filed